637
65
Investing in multi-agent AI safety research
Google DeepMind and partners announce a $10M funding call for multi-agent safety research.
Fluid, natural voice translation with Gemini 3.5 Live Translate
Gemini 3.5 Live Translate brings near real-time, natural speech translation to Google AI Studio, Google Translate and Google Meet.
Measuring the impact of learning with AI in Sierra Leone and beyond
Results from a randomized controlled trial show the potential of Gemini’s Guided Learning feature to boost engagement and accelerate learning.
Google just redesigned the search box for the first time in 25 years — here’s why it matters more than you think.
For a quarter century, the Google search box has been one of the most recognizable interfaces in computing: a thin white rectangle, a blinking cursor…
Fast-tracking genetic leads to reverse cellular aging
Biologists use Co-Scientist to find novel factors that successfully rejuvenate human cells.
Simulate real-world places with Project Genie and Street View
We’re expanding access to Google AI Ultra subscribers globally and introducing a new capability powered by Street View.
Gemini for Science: AI experiments and tools for a new era of discovery
A collection of science tools and experiments to expand the scale and precision of scientific exploration.
Making it easier to understand how content was created and edited
We're expanding our tools to help you understand how content was created and edited across the web.
Strengthening Singapore’s AI Future: A New National Partnership
Google DeepMind and Singapore partner to apply frontier AI to address complex challenges across health, education, and sustainability and more.
Finding the molecular switches behind new infectious diseases
Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
Opening new paths in aging research
Calico Life Sciences uses Co-Scientist to connect scattered findings and generate new leads in aging research.
Accelerating discovery of liver disease mechanisms
Filippo Menolascina uses Co-Scientist to identify new liver disease treatments and explain why existing drugs only help certain patients.
Uniting biological toolkits for a new approach to ALS
Co-Scientist unites Boston Children’s Hospital and MIT’s labs to explore new RNA-based treatments for ALS.
Uncovering repurposed medicines to fight liver fibrosis
Stanford geneticist uses Co-Scientist to help find new treatments for chronic liver disease and liver fibrosis.